no image available Dickens & Co. "Dosing Up: A Breakthrough in Combining Nintedanib with Docetaxel for Enhanced Tolerability" "Uncovering the Power of Synergy in Cancer Treatment: Nintedanib BIBF 1120 and Docetaxel Combine Forces to Combat Malignancies" Price: 15.00€